Persistent Symptomatic Atrial Fibrillation clinical trials

Explore recruiting persistent symptomatic atrial fibrillation clinical trials.

Recruiting persistent symptomatic atrial fibrillation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Persistent Symptomatic Atrial Fibrillation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First-line cryoablation for early treatment of Persistent Atrial Fibrillation – a randomized study comparing early trigger isolation using the Cryoballoon versus antiarrhythmic medication

Sweden, Hungary, Slovakia, Norway, Germany, Denmark +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Persistent Symptomatic Atrial Fibrillation trials by city

Persistent Symptomatic Atrial Fibrillation in Toronto Persistent Symptomatic Atrial Fibrillation in Vancouver Persistent Symptomatic Atrial Fibrillation in Montreal Persistent Symptomatic Atrial Fibrillation in Calgary Persistent Symptomatic Atrial Fibrillation in Edmonton Persistent Symptomatic Atrial Fibrillation in Ottawa Persistent Symptomatic Atrial Fibrillation in Winnipeg Persistent Symptomatic Atrial Fibrillation in Quebec City Persistent Symptomatic Atrial Fibrillation in Hamilton Persistent Symptomatic Atrial Fibrillation in Kitchener Persistent Symptomatic Atrial Fibrillation in London Persistent Symptomatic Atrial Fibrillation in Halifax Persistent Symptomatic Atrial Fibrillation in New York Persistent Symptomatic Atrial Fibrillation in Los Angeles Persistent Symptomatic Atrial Fibrillation in Chicago Persistent Symptomatic Atrial Fibrillation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease